Device Trial Radar · NCT02643849
Use of The Spanner Temporary Prostatic Stent as an Alternative to a Urinary Catheter to Achieve Bladder Drainage in Men
Last checked: Nov 19, 2026Latest source record: Nov 19, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
107
Actual
Start
Aug 2016
Primary completion
Jan 2019
Study completion Feb 2019
Sponsor
- Lead sponsor
- SRS MedicalNot on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 31, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Male only, from 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The Spanner is being evaluated for use to manage voiding dysfunction and lower urinary tract symptoms in subjects to achieve bladder drainage in men unfit for other treatments.
Conditions
- Urinary Retention
Interventions
The Spanner Temporary Prostatic StentDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants Who Achieved Post-void Residual (PVR) of ≤150 ml Over 90 DaysTime frame: 90 days
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Atlantic Urology
Daytona Beach, Florida
Advanced Urology Specialists
Oxford, Florida
Urology Specialists of West Florida
Palm Harbor, Florida
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.